Seres Therapeutics, Inc. (MCRB) Current Reports & Earnings Releases
Upcoming
- 2026-11-04 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-08-04 | 8-K | Material Agreement, Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2026-07-08 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-08 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-06-05 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-01 | 8-K | Officer / Director Changes | SEC |
| 2026-05-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-16 | 8-K | Other Events | SEC |
| 2026-03-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-02 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-11-05 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-03 | 8-K | Other Events | SEC |
| 2025-08-06 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-07-22 | 8-K | Officer / Director Changes | SEC |
| 2025-05-07 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-04-22 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-04-14 | 8-K | Officer / Director Changes, Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-27 | 8-K | Officer / Director Changes | SEC |
| 2025-02-06 | 8-K | Officer / Director Changes | SEC |
| 2025-01-13 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-10 | 8-K | Results of Operations, Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-13 | 8-K | Results of Operations, Listing Notice, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-01 | 8-K | Material Agreement, Termination of Agreement, Acquisition or Disposition, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-09-26 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-09-12 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-15 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-06 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-06 | 8-K | Material Agreement, Termination of Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-07 | 8-K | Item 2.04 | SEC |
| 2024-04-23 | 8-K | Listing Notice | SEC |
| 2024-04-08 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-03-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-26 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-30 | 8-K | Other Events | SEC |
| 2024-01-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-02 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.